We were interested in determining the associations between the MoCA and long-form measures with AD neuroimaging biomarkers, so we selected participants based on the availability of at least 1 amyloid PET scan, 1 tau PET scan, and a volumetric MRI that were collected within 1 year of each other. This evidence concerns the gene MAPT and Alzheimer disease.